Cargando…
Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
Sotelo proposes that a third party, appointed by academic institutions, must be compulsorily placed between clinical researchers and drug companies.
Autor principal: | Sotelo, Julio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489183/ https://www.ncbi.nlm.nih.gov/pubmed/16805651 http://dx.doi.org/10.1371/journal.pmed.0030306 |
Ejemplares similares
-
Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005) -
Industry-Sponsored Research: Author's Reply
por: Sotelo, Julio
Publicado: (2006) -
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
por: Unger, Joseph M, et al.
Publicado: (2020) -
Four Proposals to Help Improve the Medical Research Literature
por: Moher, David, et al.
Publicado: (2015) -
The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
por: Flick, E Dawn, et al.
Publicado: (2023)